Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

NCT05787249 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT05787249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05787249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Completed
Start date
October 4, 2023
Completion date
April 4, 2025
Enrollment
1,358 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer